Form 8-K - Current report:
SEC Accession No. 0001628280-21-011975
Filing Date
2021-06-10
Accepted
2021-06-10 13:15:55
Documents
13
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20210609.htm   iXBRL 8-K 35818
2 EX-99.1 exhibit991pressrelease06-1.htm EX-99.1 7791
  Complete submission text file 0001628280-21-011975.txt   188754

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20210609.xsd EX-101.SCH 1949
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20210609_lab.xml EX-101.LAB 25483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20210609_pre.xml EX-101.PRE 13281
6 EXTRACTED XBRL INSTANCE DOCUMENT cort-20210609_htm.xml XML 11017
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 211007583
SIC: 2834 Pharmaceutical Preparations